Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This protocol describes development and user testing of an educational shared decision making intervention to help men with prostate cancer who are on active surveillance make decisions with their health care providers about if and when to de-escalate surveillance testing. The project is important because for many patients their cancer does not progress to the point of needed curative treatment or their health status changes such that they are no longer good candidates for treatment. For these men, de-escalating ongoing surveillance (e.g., fewer biopsies or imaging studies) is a reasonable option.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Mężczyźni w wieku 65 lat lub starsi
- •Rozpoznany rak prostaty w stadium lokalnym
- •Aktywne monitorowanie przez co najmniej 12 miesięcy
- •Biegłość w języku angielskim
- •Opiekunowie w wieku 18 lat lub starsi zaangażowani w opiekę nad pacjentem
- •Personel medyczny opiekujący się pacjentami z rakiem prostaty (onkolodzy, urolodzy, pielęgniarki)
✗ Disqualifies
- •Aktualnie otrzymywanie leczenia z powodu innego nowotworu
Simplified criteria — AI translation
Trial details
- Minimum age
- 65 Years
- Last updated (source)
- October 7, 2026
- Sex
- Male only
Therapies / drugs in trial
Locations (1)
M D Anderson Cancer Center
Houston, United States
Trial contact
Lisa Lowenstein, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/8/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.